​

Funding Round

Series A - Atsena Therapeutics

Series A - Atsena Therapeutics

Investment Firm

Overview

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Announced Date

Dec 16, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

7

Investor Name
Participant InvestorSofinnova Investments
Participant InvestorAbingworth
Participant InvestorLightstone Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Atsena Therapeutics raised $55000000 on 2020-12-16 in Series A

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 01, 2020
Series A - Atsena Therapeutics
5-8.2M
Dec 16, 2020
Series A - Atsena Therapeutics
8-55.0M
Oct 02, 2023
Venture Round - Atsena Therapeutics
-24.5M

Recent Activity

There is no recent news or activity for this profile.